Megaloblastic anaemia associated with combined pyrimethamine and co-trimoxazole administration.
D000328:Adult; D000748:Anemia, Macrocytic / Q000139:chemically induced*; D000749:Anemia, Megaloblastic / Q000139:chemically induced*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D005334:Fever / Q000188:drug therapy; D006801:Humans; D008288:Malaria / Q000517:prevention & control; D011739:Pyrimethamine / Q000009:adverse effects* / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000009:adverse effects* / Q000627:therapeutic use; D014295:Trimethoprim / Q000009:adverse effects* / Q000627:therapeutic use
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole; D011739:Pyrimethamine